Plus Brigham and Women’ plans to phase out Dana-Farber PAs

February 16, 2026

1. 11 cancer leaders, researchers make Time's latest health list Full story

2. Another win for GLP-1s and cancer risk: 5 study notes Full story

3. Leaders from Fox Chase Cancer & Orlando Health weigh in on the oncology workforce cliff here.

 

4. Brigham and Women's to phase out Dana-Farber PAs: Boston Globe Full story

5. Cleveland Clinic Florida taps radiation oncology chair Full story

6. UCI Health expands capacity of stem-cell program by 200% Full story

 

7. NIH updates 'clinical trial' definition: What to know Full story

8. City of Hope reignites its commercialization engine Full story

9. Prostate cancer diagnoses up 23% among young adults, Epic data shows Full story

10. St. Charles Health System to open $65M cancer center Full story

 

Becker's Learning Opportunities

11. Rush cut infusion wait times 50%. Their capacity + ops strategy: here.

12. Thriving vs. surviving: What sets top ASCs apart? See 6 defining traits here.

13. Some health systems generate $20M annually from home infusion. Why many still hesitate — here.

14. Interested in more? See Becker’s full lineup of webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication